Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Articles
  • Issues

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Genetics
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues

Share

April 2019; 5 (2) Clinical/Scientific NotesOpen Access

Leaky splicing variant in sepiapterin reductase deficiency

Are milder cases escaping diagnosis?

Yu Nakagama, Kohei Hamanaka, Masakazu Mimaki, Haruo Shintaku, Satoko Miyatake, Naomichi Matsumoto, Koji Hirohata, Ryo Inuzuka, Akira Oka
First published March 25, 2019, DOI: https://doi.org/10.1212/NXG.0000000000000319
Yu Nakagama
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kohei Hamanaka
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masakazu Mimaki
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haruo Shintaku
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoko Miyatake
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naomichi Matsumoto
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koji Hirohata
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryo Inuzuka
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Oka
From the Department of Pediatrics (Y.N., K. Hirohata, R.I., A.O.), Graduate School of Medicine, The University of Tokyo; Department of Human Genetics (K. Hamanaka, S.M., N.M.), Graduate School of Medicine, Yokohama City University; Department of Pediatrics (M.M.), School of Medicine, Teikyo University, Tokyo; and Department of Pediatrics (H.S.), Graduate School of Medicine, Osaka City University, Osaka, Japan.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Leaky splicing variant in sepiapterin reductase deficiency
Are milder cases escaping diagnosis?
Yu Nakagama, Kohei Hamanaka, Masakazu Mimaki, Haruo Shintaku, Satoko Miyatake, Naomichi Matsumoto, Koji Hirohata, Ryo Inuzuka, Akira Oka
Neurol Genet Apr 2019, 5 (2) e319; DOI: 10.1212/NXG.0000000000000319

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
546

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Sepiapterin reductase deficiency (SRD), an extremely rare but treatable neurotransmitter disease, is an enzyme defect in the final step of tetrahydrobiopterin (BH4) synthesis.1 Unlike other forms of BH4-deficient dopa-responsive dystonia, SRD uniquely does not manifest hyperphenylalaninemia and thus slips through detection by newborn screening. Owing to its variable presenting features and need for a sensitive method of CSF analysis, diagnosis of SRD may be compromised in mild phenotypes.2

We describe a novel splice site variant leading to leaky splicing control of the SPR gene. Our observation adds evidence to the notion that leaky splicing may take part in SRD heterogeneity and evokes the image of an iceberg beneath the water: patients at the milder end of the spectrum escaping recognition.

Case report

An 8-month-old girl presented with postural limb dystonia that worsened in the evening. Brain imaging, EEG, routine blood, urine, and CSF testing were nondiagnostic. Recognition of her episodic oculogyric crises and convergence spasms prompted us to analyze her CSF for pterins and biogenic amines. CSF homovanillic acid (132 nmol/L) and 5-hydroxyindoleacetic acid (11.5 nmol/L) were decreased (normal range: 295–932 nmol/L and 114–336 nmol/L, respectively). The CSF BH4 level, analyzed by the method described by Fukushima and Nixon,3 was below the detection limit, whereas total biopterin (27.06 nmol/L) and neopterin (22.06 nmol/L) levels were within the normal range, suggesting that most of the patient's total biopterin was a sum of biopterin and dihydrobiopterin. Findings were suggestive of monoamine neurotransmitter disease due to BH4 deficiency. l-dopa/carbidopa therapy completely suppressed her dystonia and resulted in near-normal psychomotor development.

Genetic analysis established the diagnosis of SRD by identifying compound heterozygous variants in the SPR gene (NM_003124.4): c.512G>A and c.304+1_+12del. The former is a novel missense variant, absent in the Exome Aggregation Consortium (ExAC) and gnomAD databases, estimated to substitute a well-conserved cysteine for tyrosine, and predicted as damaging according to in silico analyses. The latter, also absent in the ExAC and gnomAD databases, destroys the 5′ splice donor site in intron 1, rendering the gene prone to aberrant splicing (figure, A).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Mutational and splicing analyses

(A) The patient was compound heterozygous for an exonic c.512G>A and an intronic c.304+1_+12del (SPR, NM_003124.4) (B and C) The destroyed splice site and retention of intron 1 resulted in a larger size 899-bp band (B, arrow) specific to the patient. Because allelic origin was identifiable based on the c.512G>A variant, sequencing the normally spliced 319-bp product (B, arrowhead) showed significant wild-type splicing from the allele carrying c.304+1_+12del (C). Primers were designed as depicted, and sequences are available upon request.

Next, splicing analysis was performed, using blood cell transcripts extracted from the patient and a healthy control. Primers were designed to flank intron 1 and exon 2 of the SPR gene and to specifically amplify the RNA sequences (figure B). Reverse transcription-PCR–based splicing analysis not only confirmed aberrant splicing causing intron retention (figure B, arrow) but also discovered evidence for leaky splicing control related to c.304+1_+12del. Because the allelic origin was identifiable based on the presence or absence of c.512G>A, directly sequencing the shorter 319-bp amplicon (figure B, arrowhead) showed significant wild-type splicing from the allele carrying c.304+1_+12del (figure C).

Discussion

Leaky splicing control contributes to phenotypic variation by affecting disease onset and/or severity. The extent of leaky wild-type transcription determines, for example, residual acid alpha-glucosidase activity in Pompe disease and relates to a specific-form of adult-onset disease.4 As for SRD, others have reported the possibility of leaky splicing causing intrafamilial heterogeneity.5 In the report, however, splicing was assessed indirectly using the minigene system. Our report proves by directly analyzing patient RNA that leaky splice site variants indeed underlie SRD. Phenotypic variability owing to such leaky splicing control may further expand the SRD spectrum.

Study funding

Supported by grants from Morinaga Hoshikai and AMED (JP18ek0109280 and JP18ek0109301).

Disclosure

Y. Nakagama has received government research support from JSPS Kakenhi and has received foundation/society research support from Morinaga Hoshikai. K. Hamanaka and M. Mimaki report no disclosures. H. Shintaku has received government research support from the AMED. S. Miyatake has received foundation/society research support from the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics, JSPS KAKENHI, and The Ichiro Kanehara Foundation for the Promotion of Medical Science & Medical Care. N. Matsumoto has served on the editorial boards of Clinical Genetics, Journal of Human Genetics, and American Journal of Medical Genetics and has received foundation/society research support from the AMED, JSPS KAKENHI, and Takeda Science Foundation. K. Hirohata reports no disclosures. R. Inuzuka has served on the editorial board of Journal of Pediatric Cardiology and Cardiac Surgery and has received government research support from JSPS KAKENHI. A. Oka has received funding for travel or speaker honoraria from Otsuka Pharmaceutical, UCB Japan, Nobelpharma, Janssen Pharmaceutical, Eisai, BioMarin Pharmaceutical, Novartis Pharma K.K., GE Healthcare Japan, Teijin Pharma Limited, Shionogi & Co., Shire Japan, Bayer Yakuhin, and SRL Inc.; has served on the editorial board of Pediatrics International; has commercial research support from Maruho Co, Pfizer Japan, Astellas Pharma, Novartis Pharma K.K., Chugai Pharmaceutical Co., and Eli Lilly Japan K.K.; and has received government funding from The Ministry of Health Labour and Welfare Japan. Disclosures available: Neurology.org/NG.

Appendix Author contributions

Table
Table

Footnotes

  • ↵* These authors contributed equally to this work.

  • Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.

  • The Article Processing Charge was funded by the authors.

  • Patient consent: Written consent for publication was obtained from the patient's family.

  • Received October 26, 2018.
  • Accepted in final form February 8, 2019.
  • Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

References

  1. 1.↵
    1. Bonafé L,
    2. Thöny B,
    3. Penzien JM,
    4. Czarnecki B,
    5. Blau N
    . Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet 2001;69:269–277.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Ng J,
    2. Papandreou A,
    3. Heales SJ,
    4. Kurian MA
    . Monoamine neurotransmitter disorders--clinical advances and future perspectives. Nat Rev Neurol 2015;11:567–584.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Fukushima T,
    2. Nixon JC
    . Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980;102:176–188.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Boerkoel CF,
    2. Exelbert R,
    3. Nicastri C, et al
    . Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 1995;56:887–897.
    OpenUrlPubMed
  5. 5.↵
    1. Arrabal L,
    2. Teresa L,
    3. Sánchez-Alcudia R, et al
    . Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant. Neurogenetics 2011;12:183–191.
    OpenUrlPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Case report
    • Discussion
    • Study funding
    • Disclosure
    • Appendix Author contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Genetics
  • All Pediatric
  • Dystonia
  • Gene expression studies
  • Metabolic disease (inherited)

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Clinical/Scientific Notes
    Very early pattern of movement disorders in sepiapterin reductase deficiency
    Vincenzo Leuzzi, Claudia Carducci, Manuela Tolve et al.
    Neurology, November 08, 2013
  • Articles
    Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome
    A new phenotype
    N. Blau, L. Bonafé, I. Krägeloh-Mann et al.
    Neurology, September 08, 2003
  • Brief Communications
    Treatable neurotransmitter deficiency in mild phenylketonuria
    L. Bonafé, N. Blau, A. P. Burlina et al.
    Neurology, September 11, 2001
  • Articles
    Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
    Y. Furukawa, T.G. Nygaard, M. Gütlich et al.
    Neurology, September 01, 1999
Neurology Genetics: 9 (6)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Genetics | Online ISSN: 2376-7839

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise